BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32767585)

  • 1. Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: A Kin Cohort Study.
    Balestrino R; Tunesi S; Tesei S; Lopiano L; Zecchinelli AL; Goldwurm S
    Mov Disord; 2020 Nov; 35(11):2111-2114. PubMed ID: 32767585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.
    Anheim M; Elbaz A; Lesage S; Durr A; Condroyer C; Viallet F; Pollak P; Bonaïti B; Bonaïti-Pellié C; Brice A;
    Neurology; 2012 Feb; 78(6):417-20. PubMed ID: 22282650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Penetrance of Parkinson's Disease in Elderly Carriers of Glucocerebrosidase Gene L444P/R Mutations: A Community-Based 10-Year Longitudinal Study.
    Ji S; Wang C; Qiao H; Gu Z; Gan-Or Z; Fon EA; Chan P
    Mov Disord; 2020 Apr; 35(4):672-678. PubMed ID: 31912918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
    McNeill A; Magalhaes J; Shen C; Chau KY; Hughes D; Mehta A; Foltynie T; Cooper JM; Abramov AY; Gegg M; Schapira AH
    Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
    Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
    J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
    Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
    Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease.
    Galper J; Balwani M; Fahn S; Waters C; Krohn L; Gan-Or Z; Dzamko N; Alcalay RN
    Mov Disord; 2021 Jun; 36(6):1451-1455. PubMed ID: 33570220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
    Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood lysosphingolipids accumulation in patients with parkinson's disease with glucocerebrosidase 1 mutations.
    Pchelina S; Baydakova G; Nikolaev M; Senkevich K; Emelyanov A; Kopytova A; Miliukhina I; Yakimovskii A; Timofeeva A; Berkovich O; Fedotova E; Illarioshkin S; Zakharova E
    Mov Disord; 2018 Aug; 33(8):1325-1330. PubMed ID: 30192031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocerebrosidase mutations in Thai patients with Parkinson's disease.
    Pulkes T; Choubtum L; Chitphuk S; Thakkinstian A; Pongpakdee S; Kulkantrakorn K; Hanchaiphiboolkul S; Tiamkao S; Boonkongchuen P
    Parkinsonism Relat Disord; 2014 Sep; 20(9):986-91. PubMed ID: 24997549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
    Barkhuizen M; Anderson DG; Grobler AF
    Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
    Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease in patients and obligate carriers of Gaucher disease.
    Becker JG; Pastores GM; Di Rocco A; Ferraris M; Graber JJ; Sathe S
    Parkinsonism Relat Disord; 2013 Jan; 19(1):129-31. PubMed ID: 22940477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease.
    Oeda T; Umemura A; Mori Y; Tomita S; Kohsaka M; Park K; Inoue K; Fujimura H; Hasegawa H; Sugiyama H; Sawada H
    Neurobiol Aging; 2015 Dec; 36(12):3306-3313. PubMed ID: 26422360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease.
    Lesage S; Anheim M; Condroyer C; Pollak P; Durif F; Dupuits C; Viallet F; Lohmann E; Corvol JC; Honoré A; Rivaud S; Vidailhet M; Dürr A; Brice A;
    Hum Mol Genet; 2011 Jan; 20(1):202-10. PubMed ID: 20947659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial sonography in patients with Parkinson's disease with glucocerebrosidase mutations.
    Kresojević N; Mijajlović M; Perić S; Pavlović A; Svetel M; Janković M; Dobričić V; Novaković I; Lakočević MB; Klein C; Kostić VS
    Parkinsonism Relat Disord; 2013 Apr; 19(4):431-5. PubMed ID: 23332636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease.
    Li Y; Sekine T; Funayama M; Li L; Yoshino H; Nishioka K; Tomiyama H; Hattori N
    Neurobiol Aging; 2014 Apr; 35(4):935.e3-8. PubMed ID: 24126159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
    Mullin S; Stokholm MG; Hughes D; Mehta A; Parbo P; Hinz R; Pavese N; Brooks DJ; Schapira AHV
    Mov Disord; 2021 Mar; 36(3):774-779. PubMed ID: 33278043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.